CCM
OMIC

Cinctive Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Cinctive Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,043
Closed -$576K – 669
2022
Q1 		$576K Buy
3,043
+666
+28% +$154K 0.02% 426
2021
Q4 		$824K Buy
+2,377
New +$921K 0.04% 428

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Cinctive Capital Management's OMIC Position: Q2 2022 in Review

Cinctive Capital Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2022, closing a stake of 3,043 shares — an estimated $576K sold.

Cinctive Capital Management first reported a position in OMIC in Q4 2021 and held it in 2 quarters. The position peaked at $824K in Q4 2021. 76 funds tracked by Wall St. Rank hold OMIC as of Q2 2022.

  • Cinctive Capital Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cinctive Capital Management sold 3,043 Singular Genomics Systems, Inc. Common Stock shares in Q2 2022, an estimated $576K.
  • Cinctive Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Cinctive Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $824K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2022.

Based on Cinctive Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.